Page 132 - MNU-PM502- Pharmaeutical Microbiology Theoritical Book
P. 132

Pharm D- Clinical Pharmacy Program        Third Level          Pharmaceutical Microbiology& Antimicrobials (PM 502)


                      •   Efflux: Resistance due to decreased accumulation by bacterial cells.
                      •    Ribosomal protection: through certain reactive protein.

                  6-  Chloramphenicol:  There  are  three  mechanisms  of  resistance  to
                  chloramphenicol:

                      •   Reduced membrane permeability.
                      •   Mutation of the 50S ribosomal subunit

                      •   Production of chloramphenicol acetyltransferase which deactivate the drug.
                  7- Macrolides
                      •   Structural changes in the target ribosomal RNA.

                      •   Production of drug-inactivating enzymes (esterases or kinases).
                      •   Production of active efflux proteins that transport the drug outside of the

                         cell.
                  8- Quinolone: Resistance due to alteration of DNA gyrase.

                  9- Rifamycins: Resistance due to mutation coding RNA polymerase


                  10- Sulfonamides and trimethoprim: Resistance due to

                      •  Plasmid codes for enzyme that has lower affinity to drug





                    Impact of Antibiotic resistance


                        1. Increase morbidity

                        2. Increased length of hospital stay


                        3. Increased healthcare costs

                        4. Increased mortality












                                                              119
   127   128   129   130   131   132   133   134   135   136   137